Decreased brain levels of 2′,3′-cyclic nucleotide-3′-phosphodiesterase in Down syndrome and Alzheimer's disease

Neurobiology of Aging

Volumn 22, Issue 4, 2001, Pages 547-553

  Vlkolinský, Roman ^a   Cairns, Nigel ^b   Fountoulakis, Michael ^c   Lubec, Gert ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Carbonic anhydrase II; MALDI MS; Myelin; Neurodegeneration; Oligodendroglia

Indexed keywords

2',3' CYCLIC NUCLEOTIDE 3' PHOSPHODIESTERASE; BRAIN ENZYME; CARBONATE DEHYDRATASE II; GLUCOSE; MYELIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN LEVEL; BRAIN REGION; BRAIN TISSUE; CELL COMMUNICATION; CELL DENSITY; CELL LOSS; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; ENZYME ACTIVITY; FEMALE; FRONTAL CORTEX; GLUCOSE METABOLISM; HUMAN; HUMAN TISSUE; MALE; MASS SPECTROMETRY; MYELINATION; NERVE FIBER; OLIGODENDROGLIA; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; TWO DIMENSIONAL ELECTROPHORESIS;

2',3'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; AGED; ALZHEIMER DISEASE; BRAIN; CARBONIC ANHYDRASES; DOWN SYNDROME; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVE DEGENERATION; OLIGODENDROGLIA; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 0034969003     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(01)00218-4     Document Type: Article

References (68)

1. Association of amyloid P component with complement proteins in neurologically diseased brain tissue
2. Triiodothyronine stimulation of oligodendroglial differentiation and myelination. A developmental study
3. Amino acid sequence of human erythrocyte carbonic anhydrase B
4. Biochemical studies on myelin isolated from the brains of patients with Down's syndrome
5. Investigation on myelination in vitro: Regulation of 2,3′-cyclic nucleotide 3′-phosphohydrolase by thyroid hormone in cultures of dissociated brain cells from embryonic mice
6. Chemical pathology of the organic dementias. II. Quantitative estimation of cellular changes in post-mortem brains
7. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
8. Brain changes in dementia of Alzheimer's type relevant to new imaging diagnostic methods
9. Neuropathology
10. Quantitation of myelin carbonic anhydrase-development and subfractionation of rat brain myelin and comparison with myelin from other species
11. Comparison of immunocytochemical staining of astrocytes, oligodendrocytes, and myelinated fibers in the brains of carbonic anhydrase II-deficient mice and normal littermates
12. Carbonic anhydrase in distinct precursors of astrocytes and oligodendrocytes in the forebrains of neonatal and young rats
13. Volumetric neuroimaging in children with neurodevelopmental disorders - Mapping the brain and behavior
14. Negative regulation of central nervous system myelination by polysialylated-neural cell adhesion molecule
15. Binding of 2′,3′-cyclic nucleotide 3′-phosphodiesterase to myelin: An in vitro study
16. Induction of myelination in central nervous system by electrical activity
17. Molecular abnormalities of the brain in Down syndrome: Relevance to Alzheimer's neurodegeneration
18. Down's syndrome and thyroid disorder
19. White matter changes in dementia of Alzheimer's type: The difference in vulnerability between cell compartments
20. Identification of proteins by matrix-assisted laser desorption ionization-mass spectrometry following in-gel digestion in low-salt, nonvolatile buffer and simplified peptide recovery
21. Immunochemical and immunohistochemical study of carbonic anhydrase II in adult rat cerebellum: A marker for oligodendrocytes
22. Decreased levels of synaptosomal associated protein 25 in the brain of patients with Down syndrome and Alzheimer's disease
23. A beta A4 amyloid precursor protein gene and Alzheimer's disease
24. Hormonal and biochemical disturbances in Down's syndrome
25. Oxidative stress and neural dysfunction in Down syndrome
26. Carbonic anhydrase II expression in fibrous astrocytes of the sheep
27. Neuroendocrine-specific protein C (NSP-C), a marker of neuronal differentiation, is reduced in brain of patients with Down syndrome and Alzheimer's disease
28. Magnetic resonance imaging evaluation of delayed myelination in Down syndrome: A case report and review of the literature
29. Effects of triiodothyronine on the synthesis of sulfolipids by oligodendrocyte-enriched glial cultures
30. Immunohistochemical localization of carbonic anhydrase isoenzyme C in human brain
31. Volumes of hippocampus, amygdala and frontal lobes in the MRI-based diagnosis of early Alzheimer's disease: Correlation with memory functions
32. Impaired brain glucose metabolism in patients with Down syndrome
33. Thyroid stimulating hormone-receptor overexpression in brain of patients with Down syndrome and Alzheimer's disease
34. Increased phosphoglycerate kinase in the brains of patients with Down's syndrome but not with Alzheimer's disease
35. Two-dimensional map of human brain proteins
36. Effect of protein application mode and acrylamide concentration on the resolution of protein spots separated by two-dimensional gel electrophoresis
37. Regulation of 2′3′-cyclic nucleotide phosphodiesterase gene expression in experimental peripheral neuropathies
38. Reduced aldehyde dehydrogenase levels in the brain of patients with Down syndrome
39. Increased glyceraldehyde 3-phosphate dehydrogenase levels in the brain of patients with Down's syndrome
40. Pivotal role of axonal adhesion molecules in central nervous system myelinization
41. Oligodendrocytes and microglia are selectively vulnerable to combined hypoxia and hypoglycemia injury in vitro
42. Sustained neonatal hyperthyroidism in the rat affects myelination in the central nervous system
43. Intracellular localization of 2′,3′-cyclic nucleotide 3′-phosphohydrolase in rat oligodendrocytes and C6 glioma cells, and effect of cell maturation and enzyme induction on localization
44. Upregulation of the hyperpolarization-activated cation current in rat thalamic relay neurones by acetazolamide
45. Astrocytic gliosis in the amygdala in Down's syndrome and Alzheimer's disease
46. Mechanisms of neuronal death in Down's syndrome
47. Immunohistochemical localization of 2′,3′-cyclic nucleotide 3′-phosphodiesterase in the central nervous system
48. Distribution of carbonic anhydrase activity in the rat central nervous system, as revealed by a new semipermeable technique
49. Selective synthesis of 2′,3′-cyclic nucleotide 3′-phosphodiesterase isoform 2 and identification of specifically phosphorylated serine residues
50. Immunohistochemical demonstration of human carbonic anhydrase isoenzyme II in brain tumours
51. b-Amyloid regulates gene expression of glial trophic substance S100b in glioma and primary astrocytes cultures
52. 2′,3′-cyclic nucleotide-3′-phosphodiesterase activity as an index of myelin in the post-mortem brains of patients with Alzheimer's disease
53. Oligodendrocyte development and thyroid hormone
54. Properties and function of brain carbonic anhydrase
55. Apoptosis-associated proteins p53 and APO-1/Fas (CD95) in brains of adult patients with Down syndrome
56. Overexpression of DNAse I in brain of patients with Down syndrome
57. Carbonic anhydrase II deficiency identified as the primary defect in the autosomal recessive syndrome of osteoporosis with renal tubular acidosis and cerebral calcification
58. Carbonic anhydrase, 5′-nucleotidase, and 2′,3′-cyclic nucleotide-3′-phosphodiesterase activities in oligodendrocytes, astrocytes, and neurons isolated from the brains of developing rats
59. Cognitive and neurologic findings in demented patients with diffuse white matter lucencies on computed tomographic scan (leuko-araiosis)
60. Membrane lipids, selectively diminished in Alzheimer brains, suggest synapse loss as a primary event in early-onset form (type I) and demyelination in late-onset form (type II)
61. Basal ganglia calcification in Down's syndrome
62. The value of inherited deficiencies of human carbonic anhydrase isozymes in understanding their cellular roles
63. Molecular structure, localization, and possible functions of the myelin-associated enzyme 2′,3′-cyclic nucleotide 3′-phosphodiesterase
64. Decreased myelin lipids in Alzheimer's disease and vascular dementia
65. Down syndrome children often have brain with maturation delay, retardation of growth, and cortical dysgenesis
66. Postnatal delay of myelin formation in brains from Down syndrome infants and children
67. CNP overexpression induces aberrant oligodendrocyte membranes and inhibits MBP accumulation and myelin compaction
68. Synaptosomal proteins beta-soluble N-ethylmaleimide-sensitive factor attachment protein (beta-SNAP), gamma-SNAP and synaptotagmin I in brain of patients with Down syndrome and Alzheimer's disease